株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

分子診断の世界市場 (用途別 (感染症、血液検査など)・技術別・地域別):市場規模、産業分析、今後の展望・成長可能性、価格動向、市場シェア、将来予測

Molecular Diagnostics Market Size By Application (Infectious Disease, Blood Screening, & Others), Technology , Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2017 - 2024

発行 Global Market Insights Inc. 商品コード 599955
出版日 ページ情報 英文 270 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=111.68円で換算しております。
Back to Top
分子診断の世界市場 (用途別 (感染症、血液検査など)・技術別・地域別):市場規模、産業分析、今後の展望・成長可能性、価格動向、市場シェア、将来予測 Molecular Diagnostics Market Size By Application (Infectious Disease, Blood Screening, & Others), Technology , Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2017 - 2024
出版日: 2017年12月06日 ページ情報: 英文 270 Pages
概要

当レポートでは、世界の分子診断の市場について分析し、業界の基本構造や求心力、技術・規制環境、主な市場促進・抑制要因、用途別・技術別・地域別の市場動向見通し (過去4年間・今後8年間分)、主要企業のプロファイル・業績・戦略などを調査しております。

第1章 分析手法と市場範囲

第2章 エグゼクティブ・サマリー

第3章 分子診断産業の分析

  • 産業区分
  • 産業情勢 (通算12年間)
    • 成長促進要因
    • 業界の陥穽と課題
  • 業界のエコシステムの分析
    • ベンダー・マトリックス
  • 成長可能性の分析
    • 用途別
    • 技術別
  • 技術環境
    • 製品開発
  • パイプライン分析
  • 価格動向分析
    • 地域別の平均価格
  • ポーターのファイブフォース分析
  • 競争環境
    • 戦略一覧
  • PESTEL分析

第4章 分子診断市場:用途別

  • 用途別の市場シェア (最新値・予測値)
  • 感染症
    • 市場規模:地域別 (金額ベース、通算12年間)
    • インフルエンザ
    • RSVウイルス
    • 結核
    • 髄膜炎
    • HIV
    • C型肝炎
    • B型肝炎
    • HPV (ヒトパピローマウイルス)
    • 性感染症 (STD)
      • クラミジア
      • 淋病
      • その他
    • デング熱
    • ヘリコバクターピロリ
    • TORCH症候群
    • その他
  • 血液検査
  • 遺伝子検査
  • 腫瘍検査

第5章 分子診断市場:技術別

  • 技術別の市場シェア (最新値・予測値)
    • 市場規模:地域別 (金額ベース、通算12年間)
  • ポリメラーゼ連鎖反応 (PCR)
  • In Situハイブリダイゼーション
  • チップ・マイクロアレイ
  • 質量分析 (MS)
  • シークエンシング
  • 等温増幅
  • その他

第6章 分子診断市場:地域別

  • 地域別の市場シェア (最新値・予測値)
  • 北米 (米国、カナダ)
    • 市場規模:地域別 (金額ベース、通算12年間)
    • 市場規模:用途別 (金額ベース、通算12年間)
    • 市場規模:技術別 (金額ベース、通算12年間)
  • 欧州 (ドイツ、英国、フランス、イタリア、スペイン、ポルトガル、デンマーク、ノルウェー、スウェーデン、ロシア)
  • アジア太平洋地域 (日本、中国、インド、オーストラリア、スリランカ、マレーシア、パキスタン、フィリピン、韓国、ニュージーランド、ベトナム、タイ)
  • ラテンアメリカ (ブラジル、メキシコ、アルゼンチン、コロンビア、チリ、ペルー)
  • アフリカ (南アフリカ、ナイジェリア、モロッコ、エジプト)
  • 中東 (サウジアラビア、UAE、ヨルダン、カタール、イスラエル)

第7章 企業プロファイル

  • Abbott Molecular
    • 事業概要
    • 財務データ
    • 製品環境
    • 戦略展望
    • SWOT分析
  • Agilent (Dako)
  • Alere Inc.
  • Analytik Jena AG
  • Becton, Dickinson and Company
  • Biocartis Group NV
  • BioFire Diagnostics
  • Biomerieux
  • Bio-Rad Laboratories
  • Bio-Techne
  • Cepheid
  • Cleaver Scientific
  • CombiMatrix
  • Danaher Corporation
  • GenMark Diagnostics
  • Genomic Health, Inc.
  • Heal Force
  • Hologic (Gen Probe)
  • HTG Molecular Diagnostics
  • Johnson & Johnson
  • MDxHealth
  • Myriad Genetics, Inc.
  • Novartis (Grifols)
  • Qiagen Gaithersburg, Inc.
  • Roche Diagnostics
  • Rosetta Genomics
  • Siemens Healthcare
  • シスメックス
目次
Product Code: 434

Title:
Molecular Diagnostics Market Size By Application (Infectious Disease, Blood Screening, Genetic Testing, Oncology Testing), By Technology (PCR, In Situ Hybridization, Chips and microarrays, Mass spectrometry, Sequencing, Isothermal Amplification), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Portugal, Italy, Russia, Denmark, Norway, Sweden, Japan, China, India, Australia, Sri Lanka, Malaysia, Pakistan, Philippines, South Korea, New Zealand, Vietnam, Thailand Brazil, Mexico, Argentina, Colombia, Chile, Peru, South Africa, Nigeria, Morocco, Egypt, KSA, UAE, Jordan, Qatar, Israel), Application Potential, Price Trends, Competitive Market Share & Forecast, 2017 - 2024.

Molecular Diagnostics Market will reach USD 12.5 billion by 2024; according to a new research report.

Rising prevalence of infectious diseases coupled with technological advancements pertaining to disease diagnosis will drive molecular diagnostics market. Further, growing geriatric population prone to suffer from chronic conditions such as cancer will generate need for early disease screening for better treatment planning.

Growing awareness about disease diagnosis and prevention has led to rising demand for point of care diagnostics. Moreover, increasing application of next generation sequencing, real time PCR to enhance molecular diagnostic testing will further propel industry growth.

Rising R&D funding by public and private organizations towards development of advanced diagnostic tools will fuel molecular diagnostics market growth. However high cost associated with molecular testing and complex regulatory landscape will impede market growth.

Infectious disease segment dominated the industry in 2016 owing to rising prevalence of infectious diseases including HIV, Tuberculosis, Dengue, Hepatitis B coupled with availability of numerous tests for infectious disease diagnosis. Growing awareness about early disease detection and numerous efforts undertaken by government to reduce disease prevalence will favor industry growth. Rising incidences of blood cancer globally will drive blood screening market over the forecast timeline.

Growing application of in-situ hybridization in identifying sites of gene expression, localizing viral infection and gene sequence mapping in chromosomes will drive in-situ hybridization market. Growing adoption of real-time PCR due to its efficiency and precise results will accelerate PCR market growth.

U.S. molecular diagnostics market dominated the industry in 2016 and is anticipated to follow similar trend over the coming years due to rising demand for advanced molecular tests, rising incidences of cancer and presence of major industry players such as Abbott and Roche.

France is attributed by high technological adoption along with initiatives including various cancer genomic profiling projects, nation-wide molecular testing for cancer undertaken by French ministry of health will drive molecular diagnostics market in France.

Growing burden of geriatric population base, rising incidences of infectious diseases and cancer coupled with increasing healthcare expenditure and awareness about disease diagnosis and prevention will drive Chinese molecular diagnostics market over the coming years.

Some of the industry players are Roche Diagnostics, Abbott, Siemens Healthcare, Becton Dickinson and Company, Alere, BioMerieux, GenMark Diagnostics, Bio-Rad Laboratories, Johnson & Johnson, Novartis, and Qiagen Gaithersburg.

Major industry players are focusing on new product development to satisfy growing consumer demand for easy operative, affordable and precise molecular diagnostic test. Acquisition, strategic collaboration and partnership are major strategies adopted by industry players to broaden their existing product portfolio as well as sustain market position.

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
    • 1.1.1. Initial data exploration
    • 1.1.2. Statistical model and forecast
    • 1.1.3. Industry insights and validation
    • 1.1.4. Market definition and forecast parameters
  • 1.2. Data Sources
    • 1.2.1. Secondary
    • 1.2.2. Primary

Chapter 2. Executive Summary

  • 2.1. Molecular diagnostics industry 360 degree synopsis, 2013 - 2024
    • 2.1.1. Business trends
    • 2.1.2. Application trends
    • 2.1.3. Technology trends
    • 2.1.4. Regional trends

Chapter 3. Molecular Diagnostics Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2013 - 2024
  • 3.3. Industry impact forces
    • 3.3.1. Growth drivers
    • 3.3.1.1. Technological advancements
    • 3.3.1.2. Growing POC demand
    • 3.3.1.3. Increasing geriatric population
    • 3.3.1.4. R&D initiatives
    • 3.3.1.5. Upward trend in disease prevalence
    • 3.3.2. Industry pitfalls & challenges
    • 3.3.2.1. Unclear regulatory landscape
    • 3.3.2.2. Cost concerns
  • 3.4. Growth potential analysis
    • 3.4.1. By application
    • 3.4.2. By technology
  • 3.5. Technology landscape
    • 3.5.1. Product innovation
  • 3.6. Pipeline analysis
  • 3.7. Pricing analysis
    • 3.7.1. Average regional prices
  • 3.8. Porter's analysis
  • 3.9. Competitive landscape, 2016
    • 3.9.1. Strategy dashboard
  • 3.10. PESTEL analysis

Chapter 4. Molecular Diagnostics Market, By Application

  • 4.1. Molecular diagnostics market share by application, 2016 & 2024
  • 4.2. Infectious disease
    • 4.2.1. Market size, by region, 2013-2024 (USD Million)
    • 4.2.2. Flu
    • 4.2.2.1. Market size, by region, 2013-2024 (USD Million)
    • 4.2.3. RSV virus
    • 4.2.3.1. Market size, by region, 2013-2024 (USD Million)
    • 4.2.4. Tuberculosis
    • 4.2.4.1. Market size, by region, 2013-2024 (USD Million)
    • 4.2.5. Meningitis
    • 4.2.5.1. Market size, by region, 2013-2024 (USD Million)
    • 4.2.6. HIV market
    • 4.2.6.1. Market size, by region, 2013-2024 (USD Million)
    • 4.2.7. Hepatitis C
    • 4.2.7.1. Market size, by region, 2013-2024 (USD Million)
    • 4.2.8. Hepatitis B
    • 4.2.8.1. Market size, by region, 2013-2024 (USD Million)
    • 4.2.9. HPV
    • 4.2.9.1. Market size, by region, 2013-2024 (USD Million)
    • 4.2.10. STD
    • 4.2.10.1. Market size, by region, 2013-2024 (USD Million)
    • 4.2.10.2. Chalmydia
        • 4.2.10.2.1. Market size, by region, 2013-2024 (USD Million)
    • 4.2.10.3. Gonorrhea
        • 4.2.10.3.1. Market size, by region, 2013-2024 (USD Million)
    • 4.2.10.4. Others
        • 4.2.10.4.1. Market size, by region, 2013-2024 (USD Million)
    • 4.2.11. Dengue
    • 4.2.11.1. Market size, by region, 2013-2024 (USD Million)
    • 4.2.12. H.Pylori
    • 4.2.12.1. Market size, by region, 2013-2024 (USD Million)
    • 4.2.13. TORCH
    • 4.2.13.1. Market size, by region, 2013-2024 (USD Million)
    • 4.2.14. Others
    • 4.2.14.1. Market size, by region, 2013-2024 (USD Million)
  • 4.3. Blood screening
    • 4.3.1. Market size, by region, 2013-2024 (USD Million)
  • 4.4. Genetic testing
    • 4.4.1. Market size, by region, 2013-2024 (USD Million)
  • 4.5. Oncology testing
    • 4.5.1. Market size, by region, 2013-2024 (USD Million)

Chapter 5. Molecular Diagnostics Market, By Technology

  • 5.1. Molecular diagnostics market share by technology, 2016 & 2024
  • 5.2. PCR
    • 5.2.1. Market size, by region, 2013-2024 (USD Million)
  • 5.3. In Situ Hybridization
    • 5.3.1. Market size, by region, 2013-2024 (USD Million)
  • 5.4. Chips and microarrays
    • 5.4.1. Market size, by region, 2013-2024 (USD Million)
  • 5.5. Mass spectrometry
    • 5.5.1. Market size, by region, 2013-2024 (USD Million)
  • 5.6. Sequencing
    • 5.6.1. Market size, by region, 2013-2024 (USD Million)
  • 5.7. Isothermal amplification
    • 5.7.1. Market size, by region, 2013-2024 (USD Million)
  • 5.8. Others
    • 5.8.1. Market size, by region, 2013-2024 (USD Million)

Chapter 6. Molecular Diagnostics Market, By Region

  • 6.1. Molecular diagnostics market share by region, 2016 & 2024
  • 6.2. North America
    • 6.2.1. Market size, by country, 2013-2024 (USD Million)
    • 6.2.2. Market size, by application, 2013-2024 (USD Million)
    • 6.2.2.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.2.2.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.2.3. Market size, by technology, 2013-2024 (USD Million)
    • 6.2.4. U.S.
    • 6.2.4.1. Market size, by application, 2013-2024 (USD Million)
        • 6.2.4.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.2.4.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.2.4.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.2.5. Canada
    • 6.2.5.1. Market size, by application, 2013-2024 (USD Million)
        • 6.2.5.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.2.5.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.2.5.2. Market size, by technology, 2013-2024 (USD Million)
  • 6.3. Europe
    • 6.3.1. Market size, by country, 2013-2024 (USD Million)
    • 6.3.2. Market size, by application, 2013-2024 (USD Million)
    • 6.3.2.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.3.2.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.3.3. Market size, by technology, 2013-2024 (USD Million)
    • 6.3.4. Germany
    • 6.3.4.1. Market size, by application, 2013-2024 (USD Million)
        • 6.3.4.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.3.4.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.3.4.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.3.5. UK
    • 6.3.5.1. Market size, by application, 2013-2024 (USD Million)
        • 6.3.5.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.3.5.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.3.5.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.3.6. France
    • 6.3.6.1. Market size, by application, 2013-2024 (USD Million)
        • 6.3.6.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.3.6.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.3.6.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.3.7. Italy
    • 6.3.7.1. Market size, by application, 2013-2024 (USD Million)
        • 6.3.7.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.3.7.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.3.7.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.3.8. Spain
    • 6.3.8.1. Market size, by application, 2013-2024 (USD Million)
        • 6.3.8.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.3.8.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.3.8.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.3.9. Portugal
    • 6.3.9.1. Market size, by application, 2013-2024 (USD Million)
        • 6.3.9.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.3.9.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.3.9.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.3.10. Denmark
    • 6.3.10.1. Market size, by application, 2013-2024 (USD Million)
        • 6.3.10.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.3.10.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.3.10.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.3.11. Norway
    • 6.3.11.1. Market size, by application, 2013-2024 (USD Million)
        • 6.3.11.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.3.11.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.3.11.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.3.12. Sweden
    • 6.3.12.1. Market size, by application, 2013-2024 (USD Million)
        • 6.3.12.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.3.12.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.3.12.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.3.13. Russia
    • 6.3.13.1. Market size, by application, 2013-2024 (USD Million)
        • 6.3.13.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.3.13.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.3.13.2. Market size, by technology, 2013-2024 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Market size, by country, 2013-2024 (USD Million)
    • 6.4.2. Market size, by application, 2013-2024 (USD Million)
    • 6.4.2.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.4.2.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.4.3. Market size, by technology, 2013-2024 (USD Million)
    • 6.4.4. Japan
    • 6.4.4.1. Market size, by application, 2013-2024 (USD Million)
        • 6.4.4.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.4.4.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.4.4.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.4.5. China
    • 6.4.5.1. Market size, by application, 2013-2024 (USD Million)
        • 6.4.5.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.4.5.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.4.5.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.4.6. India
    • 6.4.6.1. Market size, by application, 2013-2024 (USD Million)
        • 6.4.6.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.4.6.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.4.6.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.4.7. Australia
    • 6.4.7.1. Market size, by application, 2013-2024 (USD Million)
        • 6.4.7.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.4.7.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.4.7.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.4.8. Sri Lanka
    • 6.4.8.1. Market size, by application, 2013-2024 (USD Million)
        • 6.4.8.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.4.8.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.4.8.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.4.9. Malaysia
    • 6.4.9.1. Market size, by application, 2013-2024 (USD Million)
        • 6.4.9.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.4.9.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.4.9.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.4.10. Pakistan
    • 6.4.10.1. Market size, by application, 2013-2024 (USD Million)
        • 6.4.10.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.4.10.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.4.10.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.4.11. Philippines
    • 6.4.11.1. Market size, by application, 2013-2024 (USD Million)
        • 6.4.11.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.4.11.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.4.11.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.4.12. South Korea
    • 6.4.12.1. Market size, by application, 2013-2024 (USD Million)
        • 6.4.12.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.4.12.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.4.12.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.4.13. New Zealand
    • 6.4.13.1. Market size, by application, 2013-2024 (USD Million)
        • 6.4.13.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.4.13.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.4.13.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.4.14. Vietnam
    • 6.4.14.1. Market size, by application, 2013-2024 (USD Million)
        • 6.4.14.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.4.14.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.4.14.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.4.15. Thailand
    • 6.4.15.1. Market size, by application, 2013-2024 (USD Million)
        • 6.4.15.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.4.15.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.4.15.2. Market size, by technology, 2013-2024 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Market size, by country, 2013-2024 (USD Million)
    • 6.5.2. Market size, by application, 2013-2024 (USD Million)
    • 6.5.2.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.5.2.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.5.3. Market size, by technology, 2013-2024 (USD Million)
    • 6.5.4. Brazil
    • 6.5.4.1. Market size, by application, 2013-2024 (USD Million)
        • 6.5.4.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.5.4.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.5.4.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.5.5. Mexico
    • 6.5.5.1. Market size, by application, 2013-2024 (USD Million)
        • 6.5.5.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.5.5.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.5.5.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.5.6. Argentina
    • 6.5.6.1. Market size, by application, 2013-2024 (USD Million)
        • 6.5.6.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.5.6.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.5.6.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.5.7. Colombia
    • 6.5.7.1. Market size, by application, 2013-2024 (USD Million)
        • 6.5.7.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.5.7.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.5.7.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.5.8. Chile
    • 6.5.8.1. Market size, by application, 2013-2024 (USD Million)
        • 6.5.8.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.5.8.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.5.8.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.5.9. Peru
    • 6.5.9.1. Market size, by application, 2013-2024 (USD Million)
        • 6.5.9.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.5.9.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.5.9.2. Market size, by technology, 2013-2024 (USD Million)
  • 6.6. Africa
    • 6.6.1. Market size, by country, 2013-2024 (USD Million)
    • 6.6.2. Market size, by application, 2013-2024 (USD Million)
    • 6.6.2.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.6.2.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.6.3. Market size, by technology, 2013-2024 (USD Million)
    • 6.6.4. South Africa
    • 6.6.4.1. Market size, by application, 2013-2024 (USD Million)
        • 6.6.4.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.6.4.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.6.4.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.6.5. Nigeria
    • 6.6.5.1. Market size, by application, 2013-2024 (USD Million)
        • 6.6.5.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.6.5.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.6.5.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.6.6. Morocco
    • 6.6.6.1. Market size, by application, 2013-2024 (USD Million)
        • 6.6.6.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.6.6.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.6.6.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.6.7. Egypt
    • 6.6.7.1. Market size, by application, 2013-2024 (USD Million)
        • 6.6.7.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.6.7.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.6.7.2. Market size, by technology, 2013-2024 (USD Million)
  • 6.7. Middle East
    • 6.7.1.1. Market size, by country, 2013-2024 (USD Million)
    • 6.7.1.2. Market size, by application, 2013-2024 (USD Million)
        • 6.7.1.2.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.7.1.2.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.7.1.3. Market size, by technology, 2013-2024 (USD Million)
    • 6.7.2. Saudi Arabia
    • 6.7.2.1. Market size, by application, 2013-2024 (USD Million)
        • 6.7.2.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.7.2.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.7.2.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.7.3. UAE
    • 6.7.3.1. Market size, by application, 2013-2024 (USD Million)
        • 6.7.3.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.7.3.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.7.3.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.7.4. Jordan
    • 6.7.4.1. Market size, by application, 2013-2024 (USD Million)
        • 6.7.4.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.7.4.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.7.4.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.7.5. Qatar
    • 6.7.5.1. Market size, by application, 2013-2024 (USD Million)
        • 6.7.5.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.7.5.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.7.5.2. Market size, by technology, 2013-2024 (USD Million)
    • 6.7.6. Israel
    • 6.7.6.1. Market size, by application, 2013-2024 (USD Million)
        • 6.7.6.1.1. Market size, by infectious disease, 2013-2024 (USD Million)
        • 6.7.6.1.1.1. Market size, by STDs, 2013-2024 (USD Million)
    • 6.7.6.2. Market size, by technology, 2013-2024 (USD Million)

Chapter 7. Company Profiles

  • 7.1. Abbott Molecular
    • 7.1.1. Business overview
    • 7.1.2. Financial data
    • 7.1.3. Product landscape
    • 7.1.4. Strategic outlook
    • 7.1.5. SWOT analysis
  • 7.2. Agilent (Dako)
    • 7.2.1. Business overview
    • 7.2.2. Financial data
    • 7.2.3. Product landscape
    • 7.2.4. Strategic outlook
    • 7.2.5. SWOT analysis
  • 7.3. Alere Inc.
    • 7.3.1. Business overview
    • 7.3.2. Financial data
    • 7.3.3. Product landscape
    • 7.3.4. Strategic outlook
    • 7.3.5. SWOT analysis
  • 7.4. Analytik Jena AG
    • 7.4.1. Business overview
    • 7.4.2. Product landscape
    • 7.4.3. Strategic outlook
    • 7.4.4. SWOT analysis
  • 7.5. Becton, Dickinson and Company
    • 7.5.1. Business overview
    • 7.5.2. Financial data
    • 7.5.3. Product landscape
    • 7.5.4. Strategic outlook
    • 7.5.5. SWOT analysis
  • 7.6. Biocartis Group NV
    • 7.6.1. Business overview
    • 7.6.2. Financial data
    • 7.6.3. Product landscape
    • 7.6.4. Strategic outlook
    • 7.6.5. SWOT analysis
  • 7.7. BioFire Diagnostics
    • 7.7.1. Business overview
    • 7.7.2. Financial data
    • 7.7.3. Product landscape
    • 7.7.4. Strategic outlook
    • 7.7.5. SWOT analysis
  • 7.8. Biomerieux
    • 7.8.1. Business overview
    • 7.8.2. Financial data
    • 7.8.3. Product landscape
    • 7.8.4. Strategic outlook
    • 7.8.5. SWOT analysis
  • 7.9. Bio-Rad Laboratories
    • 7.9.1. Business overview
    • 7.9.2. Financial data
    • 7.9.3. Product landscape
    • 7.9.4. Strategic outlook
    • 7.9.5. SWOT analysis
  • 7.10. Bio-Techne
    • 7.10.1. Business overview
    • 7.10.2. Financial data
    • 7.10.3. Strategic outlook
    • 7.10.4. SWOT analysis
  • 7.11. Cepheid
    • 7.11.1. Business overview
    • 7.11.2. Financial data
    • 7.11.3. Product landscape
    • 7.11.4. Strategic outlook
    • 7.11.5. SWOT analysis
  • 7.12. Cleaver Scientific
    • 7.12.1. Business overview
    • 7.12.2. Product landscape
    • 7.12.3. SWOT analysis
  • 7.13. CombiMatrix
    • 7.13.1. Business overview
    • 7.13.2. Financial data
    • 7.13.3. Product landscape
    • 7.13.4. Strategic outlook
    • 7.13.5. SWOT analysis
  • 7.14. Danaher Corporation
    • 7.14.1. Business overview
    • 7.14.2. Financial data
    • 7.14.3. Product landscape
    • 7.14.4. Strategic outlook
    • 7.14.5. SWOT analysis
  • 7.15. GenMark Diagnostics
    • 7.15.1. Business overview
    • 7.15.2. Financial data
    • 7.15.3. Product landscape
    • 7.15.4. Strategic outlook
    • 7.15.5. SWOT analysis
  • 7.16. Genomic Health, Inc.
    • 7.16.1. Business overview
    • 7.16.2. Financial data
    • 7.16.3. Product landscape
    • 7.16.4. Strategic outlook
    • 7.16.5. SWOT analysis
  • 7.17. Heal Force
    • 7.17.1. Business overview
    • 7.17.2. Financial data
    • 7.17.3. Product landscape
    • 7.17.4. SWOT analysis
  • 7.18. Hologic (Gen Probe)
    • 7.18.1. Business overview
    • 7.18.2. Financial data
    • 7.18.3. Product landscape
    • 7.18.4. Strategic outlook
    • 7.18.5. SWOT analysis
  • 7.19. HTG Molecular Diagnostics
    • 7.19.1. Business overview
    • 7.19.2. Financial data
    • 7.19.3. Product landscape
    • 7.19.4. Strategic outlook
    • 7.19.5. SWOT analysis
  • 7.20. Johnson & Johnson
    • 7.20.1. Business overview
    • 7.20.2. Financial data
    • 7.20.3. Product landscape
    • 7.20.4. Strategic outlook
    • 7.20.5. SWOT analysis
  • 7.21. MDxHealth
    • 7.21.1. Business overview
    • 7.21.2. Financial data
    • 7.21.3. Product landscape
    • 7.21.4. Strategic outlook
    • 7.21.5. SWOT analysis
  • 7.22. Myriad Genetics, Inc.
    • 7.22.1. Business overview
    • 7.22.2. Financial data
    • 7.22.3. Product landscape
    • 7.22.4. Strategic outlook
    • 7.22.5. SWOT analysis
  • 7.23. Novartis (Grifols)
    • 7.23.1. Business overview
    • 7.23.2. Financial data
    • 7.23.3. Product landscape
    • 7.23.4. Strategic outlook
    • 7.23.5. SWOT analysis
  • 7.24. Qiagen Gaithersburg, Inc.
    • 7.24.1. Business overview
    • 7.24.2. Financial data
    • 7.24.3. Product landscape
    • 7.24.4. Strategic outlook
    • 7.24.5. SWOT analysis
  • 7.25. Roche Diagnostics
    • 7.25.1. Business overview
    • 7.25.2. Financial data
    • 7.25.3. Product landscape
    • 7.25.4. Strategic outlook
    • 7.25.5. SWOT analysis
  • 7.26. Rosetta Genomics
    • 7.26.1. Business overview
    • 7.26.2. Financial data
    • 7.26.3. Product landscape
    • 7.26.4. Strategic outlook
    • 7.26.5. SWOT analysis
  • 7.27. Siemens Healthcare
    • 7.27.1. Business overview
    • 7.27.2. Financial data
    • 7.27.3. Product landscape
    • 7.27.4. Strategic outlook
    • 7.27.5. SWOT analysis
  • 7.28. Sysmex
    • 7.28.1. Business overview
    • 7.28.2. Financial data
    • 7.28.3. Product landscape
    • 7.28.4. Strategic outlook
    • 7.28.5. SWOT analysis

List Tables

  • TABLE 1: Molecular diagnostics industry 360 degree synopsis, 2013 - 2024
  • TABLE 2: Global molecular diagnostics market, 2013 - 2024 (USD Million)
  • TABLE 3: Global molecular diagnostics market, by application, 2013 - 2024 (USD Million)
  • TABLE 4: Global molecular diagnostics market, by technology, 2013 - 2024 (USD Million)
  • TABLE 5: Global molecular diagnostics market, by region, 2013 - 2024 (USD Million)
  • TABLE 6: Industry impact forces
  • TABLE 7: Molecular diagnostics market, pipeline analysis
  • TABLE 8: Infectious disease market size, by region, 2013 - 2024 (USD Million)
  • TABLE 9: Flu market size, by region, 2013 - 2024 (USD Million)
  • TABLE 10: RSV virus market size, by region, 2013 - 2024 (USD Million)
  • TABLE 11: Tuberculosis market size, by region, 2013 - 2024 (USD Million)
  • TABLE 12: Meningitis market size, by region, 2013 - 2024 (USD Million)
  • TABLE 13: HIV market size, by region, 2013 - 2024 (USD Million)
  • TABLE 14: Hepatitis C market size, by region, 2013 - 2024 (USD Million)
  • TABLE 15: Hepatitis B market size, by region, 2013 - 2024 (USD Million)
  • TABLE 16: HPV market size, by region, 2013 - 2024 (USD Million)
  • TABLE 17: STD market size, by region, 2013 - 2024 (USD Million)
  • TABLE 18: Chalmydia market size, by region, 2013 - 2024 (USD Million)
  • TABLE 19: Gonorrhea market size, by region, 2013 - 2024 (USD Million)
  • TABLE 20: Others market size, by region, 2013 - 2024 (USD Million)
  • TABLE 21: Dengue market size, by region, 2013 - 2024 (USD Million)
  • TABLE 22: H.Pylori market size, by region, 2013 - 2024 (USD Million)
  • TABLE 23: TORCH market size, by region, 2013 - 2024 (USD Million)
  • TABLE 24: Others market size, by region, 2013 - 2024 (USD Million)
  • TABLE 25: Blood screening market size, by region, 2013 - 2024 (USD Million)
  • TABLE 26: Genetic testing market size, by region, 2013 - 2024 (USD Million)
  • TABLE 27: Oncology testing market size, by region, 2013 - 2024 (USD Million)
  • TABLE 28: PCR testing market size, by region, 2013 - 2024 (USD Million)
  • TABLE 29: In Situ Hybridization market size, by region, 2013 - 2024 (USD Million)
  • TABLE 30: Chips and microarrays testing market size, by region, 2013 - 2024 (USD Million)
  • TABLE 31: Mass spectrometry testing market size, by region, 2013 - 2024 (USD Million)
  • TABLE 32: Sequencing testing market size, by region, 2013 - 2024 (USD Million)
  • TABLE 33: Isothermal amplification testing market size, by region, 2013 - 2024 (USD Million)
  • TABLE 34: Others market size, by region, 2013 - 2024 (USD Million)
  • TABLE 35: North America molecular diagnostics market size, by country, 2013 - 2024 (USD Million)
  • TABLE 36: North America molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 37: North America molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 38: North America molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 39: North America molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 40: U.S. molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 41: U.S. molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 42: U.S. molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 43: U.S. molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 44: Canada molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 45: Canada molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 46: Canada molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 47: Canada molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 48: Europe molecular diagnostics market size, by country, 2013 - 2024 (USD Million)
  • TABLE 49: Europe molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 50: Europe molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 51: Europe molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 52: Europe molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 53: Germany molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 54: Germany molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 55: Germany molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 56: Germany molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 57: UK molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 58: UK molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 59: UK molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 60: UK molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 61: France molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 62: France molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 63: France molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 64: France molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 65: Italy molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 66: Italy molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 67: Italy molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 68: Italy molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 69: Spain molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 70: Spain molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 71: Spain molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 72: Spain molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 73: Portugal molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 74: Portugal molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 75: Portugal molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 76: Portugal molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 77: Denmark molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 78: Denmark molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 79: Denmark molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 80: Denmark molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 81: Norway molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 82: Norway molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 83: Norway molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 84: Norway molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 85: Sweden molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 86: Sweden molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 87: Sweden molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 88: Sweden molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 89: Russia molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 90: Russia molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 91: Russia molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 92: Russia molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 93: Asia Pacific molecular diagnostics market size, by country, 2013 - 2024 (USD Million)
  • TABLE 94: Asia Pacific molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 95: Asia Pacific molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 96: Asia Pacific molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 97: Asia Pacific molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 98: Japan molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 99: Japan molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 100: Japan molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 101: Japan molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 102: China molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 103: China molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 104: China molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 105: China molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 106: India molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 107: India molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 108: India molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 109: India molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 110: Australia molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 111: Australia molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 112: Australia molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 113: Australia molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 114: Sri Lanka molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 115: Sri Lanka molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 116: Sri Lanka molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 117: Sri Lanka molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 118: Malaysia molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 119: Malaysia molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 120: Malaysia molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 121: Malaysia molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 122: Pakistan molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 123: Pakistan molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 124: Pakistan molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 125: Pakistan molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 126: Philippines molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 127: Philippines molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 128: Philippines molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 129: Philippines molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 130: South Korea molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 131: South Korea molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 132: South Korea molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 133: South Korea molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 134: New Zealand molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 135: New Zealand molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 136: New Zealand molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 137: New Zealand molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 138: Vietnam molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 139: Vietnam molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 140: Vietnam molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 141: Vietnam molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 142: Thailand molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 143: Thailand molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 144: Thailand molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 145: Thailand molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 146: Latin America molecular diagnostics market size, by country, 2013 - 2024 (USD Million)
  • TABLE 147: Latin America molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 148: Latin America molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 149: Latin America molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 150: Latin America molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 151: Brazil molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 152: Brazil molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 153: Brazil molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 154: Brazil molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 155: Mexico molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 156: Mexico molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 157: Mexico molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 158: Mexico molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 159: Argentina molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 160: Argentina molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 161: Argentina molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 162: Argentina molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 163: Colombia molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 164: Colombia molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 165: Colombia molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 166: Colombia molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 167: Chile molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 168: Chile molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 169: Chile molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 170: Chile molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 171: Peru molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 172: Peru molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 173: Peru molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 174: Peru molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 175: Africa molecular diagnostics market size, by country, 2013 - 2024 (USD Million)
  • TABLE 176: Africa molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 177: Africa molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 178: Africa molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 179: Africa molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 180: South Africa molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 181: South Africa molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 182: South Africa molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 183: South Africa molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 184: Nigeria molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 185: Nigeria molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 186: Nigeria molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 187: Nigeria molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 188: Morocco molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 189: Morocco molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 190: Morocco molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 191: Morocco molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 192: Egypt molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 193: Egypt molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 194: Egypt molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 195: Egypt molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 196: Middle East molecular diagnostics market size, by country, 2013 - 2024 (USD Million)
  • TABLE 197: Middle East molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 198: Middle East molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 199: Middle East molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 200: Middle East molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 201: Saudi Arabia molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 202: Saudi Arabia molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 203: Saudi Arabia molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 204: Saudi Arabia molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 205: UAE molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 206: UAE molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 207: UAE molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 208: UAE molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 209: Jordan molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 210: Jordan molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 211: Jordan molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 212: Jordan molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 213: Qatar molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 214: Qatar molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 215: Qatar molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 216: Qatar molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)
  • TABLE 217: UAE molecular diagnostics market size, by application, 2013 - 2024 (USD Million)
  • TABLE 218: Israel molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)
  • TABLE 219: Israel molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)
  • TABLE 220: Israel molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)

List of Figures

  • FIG 1: Industry segmentation
  • FIG 2: Global molecular diagnostics market, 2013 - 2024 (USD Million)
  • FIG 3: Growth potential analysis, by application
  • FIG 4: Growth potential analysis, by technology
  • FIG 5: Comparative study between conventional culture method and molecular testing method
  • FIG 6: Average regional pricing (Molecular diagnostic test)
  • FIG 7: Porter's analysis
  • FIG 8: Strategy dashboard
  • FIG 9: PESTEL analysis
  • FIG 10: Molecular diagnostics market share by application, 2016 & 2024
  • FIG 11: Molecular diagnostics market share by technology, 2016 & 2024
  • FIG 12: Molecular diagnostics market share by region, 2016 & 2024
Back to Top